The genetic I148M variant of the gene coding for PNPLA3 has been strongly and widely correlated with a higher risk of developing severe hepatic fibrosis in patients with NAFLD/NASH [19] and other forms of liver diseases such as alcoholic hepatitis, viral hepatitis B and C and liver cancer [19]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.